BelHealth Acquires Majority Share of Linden Care

BelHealth Investment Partners has acquired Linden Care. Linden Care, headquartered in Syosset, NY, provides specialty pharmacy services to the pain management industry.

PRESS RELEASE

BelHealth Investment Partners (“BelHealth”), a healthcare-focused private equity firm, announced today that it has completed its acquisition of Linden Care LLC (“Linden Care” or the “Company”).
Linden Care, headquartered in Syosset, NY, provides specialty pharmacy services to the pain management industry. Since inception, the Company has distinguished itself by providing robust and differentiated compliance practices as well as a full suite of “specialty” services to meet the needs of patients, physicians, pharmaceutical manufacturers and professional sports teams. The Company will continue to expand this successful strategy, currently focused on the Northeast, throughout the rest of the country, becoming the national center of excellence for pain management.
Mark Bortnick, Founder and Chief Operating Officer of Linden Care said, “BelHealth is the perfect partner to accelerate Linden Care’s growth from a regional company to a national platform. BelHealth’s significant experience as operators and investors, particularly in the pharmacy space, make them the ideal equity partner for our Company. We are excited to remain significant owners and partners as we work together to grow Linden Care. Additionally, we are excited to collaborate with two of BelHealth’s current portfolio companies, Qforma and Town Total, which offer multiple partnership opportunities”.
Marc Wiener, Chief Executive Officer of Linden Care said, “I am excited to partner with BelHealth and continue serving the large and growing population suffering from severe and chronic pain. The $20 billion chronic pain industry is increasing rapidly and in dire need of a national pain management pharmacy with best-in-class compliance. We have established the foundation of a national platform and with BelHealth’s specialty pharmacy industry expertise and resources, Linden Care is well positioned to become the national center of excellence in pain control”.
Harold S. Blue, BelHealth’s Managing Partner said, “Specialty pharmacy continues to be a key focus area for BelHealth given the favorable industry trends and our firm’s collective experience in the sector. The pain management industry is a particularly attractive segment because it impacts such a broad population from cancer patients to the severely injured. Further, pain management requires a greater level of service and compliance than has been historically delivered and we are confident Linden Care’s service model fills a void in the marketplace today. Linden Care has received substantial recognition for their best-in-class compliance programs and we are excited to build upon this platform and success. We anticipate replicating Linden Care’s successful strategy in three to four regions beyond the Northeast and becoming the national leader in the pain management pharmacy space”.
126 East 56th Street, 10th Floor 4100 Newport Place, Suite 255 26 Harbor Park Drive
New York, NY 10022 Newport Beach, CA 92660 Port Washington, NY 11050
T: 347-308-7011 T: 949-200-6547 T: 516-626-5678
About Linden Care
Linden Care, headquartered in Syosset, NY, is a leading provider of specialty pharmacy services to the pain management industry. The Company offers comprehensive and highly personalized specialty pharmacy services targeting multiple growth markets through a unique “concierge pharmacy” business model. Since inception, the Company has distinguished itself by providing robust and differentiated compliance practices as well as a full suite of “specialty” services to meet the needs of patients, physicians, pharmaceutical manufacturers and professional sports teams. The Company will continue to expand this successful strategy, currently focused on the Northeast, throughout the rest of the country, becoming the national center of excellence for pain management.
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth acquires majority positions in entrepreneur-owned companies we believe would benefit from our vast operating and private equity experience. The firm typically invests $10-25 million per platform company across three healthcare segments: Services, Information Technology and Products & Distribution. Applying an active, hands-on approach, BelHealth utilizes its experience to support management to drive revenue, profit growth and achieve superior returns for our investors and partners.
For further information, please visit:
Linden Care: www.lindencare.com
BelHealth Investment Partners: www.belhealth.com
Contact
Linden Care: Marc Wiener and Mark Bortnick (516) 221-7600
BelHealth Investment Partners: Inder Tallur (347) 308-7018

Leave a Reply

PEHUB Community

Join the 12505 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget